Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Multiple Sclerosis

Free Subscription 19.12.2011 1 Acta Neurol Scand 2 Ann N Y Acad Sci 3 Ann Neurol 1 Arch Neurol 2 Arch Phys Med Rehabil 1 BMC Neurol 1 BMJ 1 Brain 3 Can J Neurol Sci 1 Eur Neurol 1 J Neuroimmunol 2 J Neurol 1 Lancet Neurol 7 Mult Scler 2 N Engl J Med 6 Neurology 1 Neurosci Lett

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Neurol Scand

1. WILLIAMSON DM , Marrie RA, Ashley-Koch A, Schiffer R, et al
   Design, methodological issues and participation in a multiple sclerosis case-control study.
   Acta Neurol Scand. 2011 Dec 16. doi: 10.1111/j.1600-0404.2011.01629.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Ann N Y Acad Sci

2. SHAIKH AG , Thurtell MJ, Optican LM, Leigh RJ, et al
   Pharmacological tests of hypotheses for acquired pendular nystagmus.
   Ann N Y Acad Sci. 2011;1233:320-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. FROHMAN TC , Davis SL, Frohman EM
   Modeling the mechanisms of Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis.
   Ann N Y Acad Sci. 2011;1233:313-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Ann Neurol

4. MOLL NM , Rietsch AM, Thomas S, Ransohoff AJ, et al
   Multiple sclerosis normal-appearing white matter: Pathology-imaging correlations.
   Ann Neurol. 2011;70:764-73.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. BOZIC C , Richman S, Plavina T, Natarajan A, et al
   Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY-1.
   Ann Neurol. 2011;70:713-21.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. PONSONBY AL , Lucas RM
   Shift work and multiple sclerosis.
   Ann Neurol. 2011;70:680-3.
   PubMed     Text format     Related articles   
   
   
   

   
   Arch Neurol

7. FILIPPI M , Rocca MA, De Stefano N, Enzinger C, et al
   Magnetic resonance techniques in multiple sclerosis: the present and the future.
   Arch Neurol. 2011;68:1514-20.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Arch Phys Med Rehabil

8. AMTMANN D , Cook KF, Johnson KL, Cella D, et al
   The PROMIS Initiative: Involvement of Rehabilitation Stakeholders in Development and Examples of Applications in Rehabilitation Research.
   Arch Phys Med Rehabil. 2011;92.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. HIRSH AT , Braden AL, Craggs JG, Jensen MP, et al
   Psychometric Properties of the Community Integration Questionnaire in a Heterogeneous Sample of Adults With Physical Disability.
   Arch Phys Med Rehabil. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   BMC Neurol

10. HULST HE , Geurts JJ
    Gray matter imaging in Multiple Sclerosis: what have we learned?
    BMC Neurol. 2011;11:153.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    BMJ

11. BARDAGE C , Persson I, Ortqvist A, Bergman U, et al
    Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden.
    BMJ. 2011;343:d5956.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Brain

12. BAGNATO F , Hametner S, Yao B, van Gelderen P, et al
    Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla.
    Brain. 2011;134.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Can J Neurol Sci

13. BURTON JM , Alikhani K, Goyal M, Costello F, et al
    Complications in MS patients after CCSVI procedures abroad (Calgary, AB).
    Can J Neurol Sci. 2011;38:741-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. DEMERS M , Rouleau I, Scherzer P, Ouellet J, et al
    Impact of the cognitive status on the memory complaints in MS patients.
    Can J Neurol Sci. 2011;38:728-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. KREMENCHUTZKY M
    Safety, not only efficacy still to be proven for controversial new MS treatment.
    Can J Neurol Sci. 2011;38:667-8.
    PubMed     Text format     Related articles   
    
    
    

    
    Eur Neurol

16. MULROY E , Joyce E, Scott J, Melling J, et al
    Long-Term Risk of Leukaemia or Cardiomyopathy after Mitoxantrone Therapy for Multiple Sclerosis.
    Eur Neurol. 2011;67:45-47.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Neuroimmunol

17. NAEGELE M , Tillack K, Reinhardt S, Schippling S, et al
    Neutrophils in multiple sclerosis are characterized by a primed phenotype.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Neurol

18. JACOBS JV , Kasser SL
    Effects of dual tasking on the postural performance of people with and without multiple sclerosis: a pilot study.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. MELIN A , Outteryck O, Collongues N, Zephir H, et al
    Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Lancet Neurol

20. GOLD R , Montalban X
    Multiple sclerosis: more pieces of the immunological puzzle.
    Lancet Neurol. 2012;11:9-10.
    PubMed     Text format     Related articles   
    
    
    

    
    Mult Scler

21. KEMPEN JC , de Groot V, Knol DL, Polman CH, et al
    Community walking can be assessed using a 10-metre timed walk test.
    Mult Scler. 2011;17:980-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. HELLWIG K , Haghikia A, Gold R
    Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment.
    Mult Scler. 2011;17:958-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. ROOSENDAAL SD , Bendfeldt K, Vrenken H, Polman CH, et al
    Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability.
    Mult Scler. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. SUMOWSKI JF , Chiaravalloti N, Erlanger D, Kaushik T, et al
    L-amphetamine improves memory in MS patients with objective memory impairment.
    Mult Scler. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. KIM W , Kim SH, Lee SH, Li XF, et al
    Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder.
    Mult Scler. 2011;17:1107-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. JARIUS S , Jacobi C, de Seze J, Zephir H, et al
    Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
    Mult Scler. 2011;17:1067-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. VIRTA JR , Laatu S, Parkkola R, Oikonen V, et al
    Cerebral acetylcholinesterase activity is not decreased in MS patients with cognitive impairment.
    Mult Scler. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    N Engl J Med

28. CALABRESI PA
    Inflammation in multiple sclerosis--sorting out the gray matter.
    N Engl J Med. 2011;365:2231-3.
    PubMed     Text format     Related articles   
    
    
    
29. LUCCHINETTI CF , Popescu BF, Bunyan RF, Moll NM, et al
    Inflammatory cortical demyelination in early multiple sclerosis.
    N Engl J Med. 2011;365:2188-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Neurology

30. LUNEMANN JD
    Epstein-Barr virus in multiple sclerosis: A continuing conundrum.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. ZIVADINOV R , Marr K
    Comment on "Chronic cerebrospinal venous insufficiency: have we found the cause and cure of MS?".
    Neurology. 2011;77:1710.
    PubMed     Text format     Related articles   
    
    
    
32. BENARROCH EE
    Nitric oxide: A pleiotropic signal in the nervous system.
    Neurology. 2011;77:1568-76.
    PubMed     Text format     Related articles   
    
    
    
33. FREEDMAN MS , Bar-Or A, Oger J, Traboulsee A, et al
    A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.
    Neurology. 2011;77:1551-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. ROVIRA A , Montalban X
    MR brain iron mapping in MS: a potential neurodegenerative marker or just another technique?
    Neurology. 2011;77:1660-1.
    PubMed     Text format     Related articles   
    
    
    
35. WOLINSKY JS , Beck CA
    The long march to surrogates of meaningful clinical outcomes in MS trials: are we there yet?
    Neurology. 2011;77:1658-9.
    PubMed     Text format     Related articles   
    
    
    

    
    Neurosci Lett

36. KRISHNAN V , Kanekar N, Aruin AS
    Anticipatory postural adjustments in individuals with multiple sclerosis.
    Neurosci Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.    Design: